Back

Rebuttal - CONTRA.

19 June 2017 (12:25 - 12:30)
Organised by:
Congress Presentation Part of: Controversies in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure Atrial fibrillation (AF) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

7 More presentations in this session

Presentation thumbnail
Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to prevent stroke and life-long anticoagulation - PRO.
Doctor D. Packer (Salt Lake City, US)
Slides Video
Presentation thumbnail
Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to prevent stroke and life-long anticoagulation - CONTRA.
Professor F. Braunschweig (Stockholm, SE)
Slides Video
Presentation thumbnail
Rebuttal - PRO.
Video
Presentation thumbnail
Rebuttal - CONTRA.
Presentation thumbnail
Ablation of atrial fibrillation should be used frequently in heart failure - PRO.
Professor L. Di Biase (The Bronx, US)
Slides Video

Access the full session

Session thumbnail
Controversies in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 12:25 CET
You may be interested in
thumbnail
Congress Session
How to manage cardiac resynchronisation therapy (CRT) challenges I
3 April 2022
thumbnail
Congress Presentation
COVID-19 infection causes a high burden of cardiovascular complications - con rebuttal
10 May 2023
thumbnail
Congress Presentation
We should target triglycerides to decrease cardiovascular risk: con
28 August 2023
thumbnail
Congress Session
Great Debate: diuretics in heart failure - friend or foe?
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources